Riboflavin-responsive glutaric aciduria type II presenting as a leukodystrophy

Graziella Uziel, Barbara Garavaglia, Elisa Ciceri, Isabella Moroni, Marco Rimoldi

Research output: Contribution to journalArticlepeer-review


The clinical phenotype of multiple acyl-CoA dehydrogenase deficiency in infancy is characterized by recurrent episodes of hypoketotic hypoglycemia and lipid storage myopathy. Brain damage has been described only as a consequence of severe and protracted hypoglycemia. We describe a child who experienced normal physical and psychomotor development until the age of 3 years, who then developed progressive intention tremors, dysarthria, ataxia, and spastic tetraparesis. Episodes of acute metabolic distress were never observed. Magnetic resonance imaging disclosed abnormal signals within the white mater of the brain and cerebellum, suggesting leukodystrophy. Gas chromatography/mass spectrometry analysis revealed abnormally high levels of glutaric acid, dicarboxylic acids, and glycine derivatives in urine. Riboflavin therapy was initiated at 4 years of age, when the patient had already lost control of trunk and head posture. Consistent improvement rapidly occurred after riboflavin supplementation. Glutaric aciduria type II may cause brain damage, in spite of the absence of acute metabolic distress, and should be considered in the differential diagnosis of leukodystrophies.

Original languageEnglish
Pages (from-to)333-335
Number of pages3
JournalPediatric Neurology
Issue number4
Publication statusPublished - 1995

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Neurology


Dive into the research topics of 'Riboflavin-responsive glutaric aciduria type II presenting as a leukodystrophy'. Together they form a unique fingerprint.

Cite this